MiMedx Group Statistics
Want to see MDXG full AI Analyst Report?
MiMedx Group (MDXG) Stock Statistics & Valuation Metrics
Total Valuation
MiMedx Group has a market cap or net worth of $464.04M. The enterprise value is $558.94M.
- Market Cap
- $464.04M
- Enterprise Value
- $558.94M
Share Statistics
MiMedx Group has 145,925,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 145,925,600
- Owned by Insiders
- 2.62%
- Owned by Institutions
- 72.50%
Financial Efficiency
MiMedx Group’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 16.66%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- 0.14
- Return on Invested Capital (ROIC)
- 16.66%
- Return on Capital Employed (ROCE)
- 0.23
- Revenue Per Employee
- 518.11K
- Profits Per Employee
- 60.12K
- Employee Count
- 808
- Asset Turnover
- 1.22
- Inventory Turnover
- 2.88
Valuation Ratios
The current PE Ratio of MiMedx Group is -24.46. MiMedx Group’s PEG ratio is 0.17.
- PE Ratio
- -24.46
- PS Ratio
- 1.53
- PB Ratio
- 2.20
- Price to FCF
- 22.79
- Price to Operating Cash Flow
- 22.37
- PEG Ratio
- 0.17
Income Statement
In the last 12 months, MiMedx Group had revenue of 418.63M and earned 48.58M in profits. Earnings per share was 0.33.
- Revenue
- 418.63M
- Gross Profit
- 345.62M
- Operating Income
- 63.89M
- Pretax Income
- 66.26M
- Net Income
- 48.58M
- EBITDA
- 82.93M
- Earnings Per Share (EPS)
- 0.33
Cash Flow
In the last 12 months, operating cash flow was 20.74M and capital expenditures -377,000, giving a free cash flow of 20.36M billion.
- Operating Cash Flow
- 20.74M
- Free Cash Flow
- 20.36M
- Free Cash Flow per Share
- 0.14
Dividends & Yields
MiMedx Group pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.36%
- Earnings Yield
- -4.11%
Stock Price Statistics
- Beta
- 0.59
- 52-Week Price Change
- -52.68%
- 50-Day Moving Average
- 4.23
- 200-Day Moving Average
- 4.14
- Relative Strength Index (RSI)
- 25.22
- Average Volume (3m)
- 1.36M
Important Dates
MiMedx Group upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
MiMedx Group as a current ratio of 4.32, with Debt / Equity ratio of 8.78%
- Current Ratio
- 4.32
- Quick Ratio
- 3.92
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -1.73
- Interest Coverage Ratio
- 35.83
Taxes
In the past 12 months, MiMedx Group has paid 17.68M in taxes.
- Income Tax
- 17.68M
- Effective Tax Rate
- 0.27
Enterprise Valuation
MiMedx Group EV to EBITDA ratio is -23.83, with an EV/FCF ratio of 17.00.
- EV to Sales
- 1.14
- EV to EBITDA
- -23.83
- EV to Free Cash Flow
- 17.00
- EV to Operating Cash Flow
- 16.69
Balance Sheet
MiMedx Group has $120.79M in cash and marketable securities with $0.00 in debt, giving a net cash position of $120.79M billion.
- Cash & Marketable Securities
- $120.79M
- Total Debt
- $0.00
- Net Cash
- $120.79M
- Net Cash Per Share
- $0.83
- Tangible Book Value Per Share
- $1.24
Margins
Gross margin is 77.29%, with operating margin of -8.28%, and net profit margin of -6.32%.
- Gross Margin
- 77.29%
- Operating Margin
- -8.28%
- Pretax Margin
- -7.37%
- Net Profit Margin
- -6.32%
- EBITDA Margin
- -4.78%
- EBIT Margin
- -7.36%
Analyst Forecast
The average price target for MiMedx Group is $7.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $7.25
- Price Target Upside
- 127.99% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- -22.80%
- EPS Growth Forecast
- -147.20%
Scores
- Smart Score
- 7
- AI Score
- 53

